2025-12-12 · Lee Tien-Li (Chief Executive Officer) · BUY
2025-12-12 · Sun Nelson (Chief Financial Officer) · BUY
2025-09-16 · Lee Tien-Li (Chief Executive Officer) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders75
Shares held10,180,129
Value$64.12M
Percent of shares outstanding46.52%
As of quarter end2026-06-30
RECENT NEWS
AARD: Aardvark Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AARD
AARD EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Aardvark Investors of Securities Class Action Lawsuit Deadline on October 13, 2026
AARD DEADLINE TUESDAY: ROSEN, A LONGSTANDING LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD
Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
AARD FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc